Mesalazine
美沙拉嗪
Report date: 2026/02/24 20:00:16
NME
Base Information
Drug NameMesalazine
Drug Alias Name +[39]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[19]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1984/01/01
Country/Territory +[49]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A
Develop Information
Active CompaniesApplied Molecular TransportShanghai Pharmaceutical Co LtdFerring Pharmaceuticals Co Ltd +[17]
Inactive CompaniesUtah State UniversityShireSandoz +[19]
Active Indications +[9]
Inactive Indications +[10]